Eric Venker - 30 Dec 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & COO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
30 Dec 2022
Net transactions value
-$889,031
Form type
4
Filing time
04 Jan 2023, 20:30:33 UTC
Previous filing
28 Dec 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale $190,088 -23,761 -2.7% $8.00 848,950 30 Dec 2022 Direct F1, F2
transaction ROIV Common Shares Sale $698,943 -95,484 -11% $7.32 753,466 03 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.
F2 A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings.